Consejo Superior De Investigaciones Cientificas Patent applications |
Patent application number | Title | Published |
20150352082 | SUBSTITUTED BENZOTHIAZOLES AND THERAPEUTIC USES THEREOF FOR THE TREATMENT OF HUMAN DISEASES - The invention relates to a family of differently substituted benzothiazoles having inhibitory activity against casein kinase 1 (CK-1) enzyme, as a result of which they are suitable for use in the treatment or prevention of diseases caused by this enzyme, particularly diseases associated with circadian rhythm and inflammatory, autoimmune, psychiatric, neurodegenerative, neurological or ophthalmic diseases, as well as for inducing cell regeneration | 12-10-2015 |
20150349501 | CONCENTRIC ELECTRICAL DISCHARGE AEROSOL CHARGER - The invention concerns an aerosol charger having electrical discharge comprising: •—a body ( | 12-03-2015 |
20150342727 | REFRACTIVE MULTIFOCAL INTRAOCULAR LENS WITH OPTIMISED OPTICAL QUALITY IN A RANGE OF FOCUS AND METHOD TO PRODUCE IT - The present invention describes a refractive multifocal intraocular lens with aspheric geometry on both surfaces in such a way that the map of local optical strength of the lens, combined with the cornea, has a central region of intermediate optical strength surrounded by a ring of maximum optica! strength, with a smooth transition between the two, after which it alternates smoothly between rings of varying strengths. | 12-03-2015 |
20150301555 | Method for Generating Piecewise-Affine Multivariable Functions with On-Line Computation of the Search Tree and Device for Implementing Same - Method for generating piecewise-affine multivariate functions, wherein the online computation of the search tree is performed in order to locate the input value in the polytopes of the partition, and the subsequent generation of the corresponding affine function. It also proposes a configurable and programmable device for generating piecewise-affine multivariate functions composed of an architecture with four functional blocks namely: a control unit block ( | 10-22-2015 |
20140366224 | PROCESS FOR MODIFYING THE ARCHITECTURE AND IMPROVING THE YIELD OF CROP PLANTS - This invention identifies the plant MINIYO (IYO) gene and the AtRTR1 gene for the initiation of cell differentiation in all plant meristems and in embryogenesis. This invention relates methods for generating transgenic plants in which expression of the IYO and/or AtRTR1 genes or their orthologous genes is modified to advancing or delaying the onset of differentiation in one or more meristems of the plant. | 12-11-2014 |
20140300949 | OPTICAL PULSE GENERATOR - An optical pulse generator and a method for using the same, where the optical pulse generator includes a source to deliver a chirped pulse and a chirped pulse compressor, and a first manipulation device and a second manipulation device capable of wavelength dependent manipulating the propagation direction of the chirped pulse and a focusing device having a predetermined focus point. The second manipulation device is arranged after the first manipulation device in propagation direction of the chirped pulse and the first and the second manipulation device are capable of manipulating the propagation direction of the chirped pulse such that the chirped pulse is transformed, after passing the second manipulation device, into a pulse, wherein different chromatic parts of the pulse are spatially spread and temporarily fully aligned. | 10-09-2014 |
20140186247 | Device and Method for the Capture of C02 by CAO Carbonation and for Maintaining Sorbent Activity - The present invention is included within the field of energy production from carbonaceous fuels with capture of carbon dioxide for its use or permanent storage and in particular relates to devices and methods which enable the improved capture of CO | 07-03-2014 |
20140072642 | ENDOTHELIAL PROGENITOR CELLS LABELLED WITH SUPERPARAMAGNETIC IRON OXIDE MICRO AND NANOPARTICLES IN CEREBROVASCULAR DISORDERS, PROCESS FOR THEIR PREPARATION AND USES THEREOF - The invention relates to the use of endothelial progenitor cells (EPC) that comprises superparamagnetic particle aggregates which are able for the preparation of a medicament. Particular nanoparticle aggregates with a coating of compounds with net negative charge, and the method for obtaining them are also disclosed. | 03-13-2014 |
20140065306 | NANOSTRUCTURED CALCIUM-SILVER PHOSPHATE COMPOSITE POWDERS, PROCESS FOR OBTAINING THE POWDERS AND BACTERICIDAL AND FUNGICIDAL APPLICATIONS THEREOF - Described in example embodiments are nanocomposite powders including calcium phosphate and silver nanoparticles on the surface of the calcium phosphate. Other example embodiments, describe methods of forming nanocomposite powders comprising a) preparing a nanometric calcium phosphate by a sol-gel processing route; and b) depositing silver nanoparticles on the calcium phosphate surface. Compositions including nanocomposite powders and uses of those compositions are also described. | 03-06-2014 |
20140005247 | CHROMENE DERIVATIVES | 01-02-2014 |
20130267588 | HYDROXYTYROSOL ETHERS - The invention relates to hydroxytyrosol ethers derived from fatty alcohols and phenolic compounds of olive oil and the salts, solvates and hydrates thereof, which have an affinity for type 1 cannabinoid receptors (CB1) and which can: prevent the oxidation of low-density lipoprotein (LDL); and modulate the actions regulated by said receptor, such as inducing satiety, controlling intake and reducing body fat. | 10-10-2013 |
20130237529 | COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES - The invention relates to a compound (I) wherein R is a heterocyclyl radical; R | 09-12-2013 |
20130236886 | Phage Phi 29 DNA Polymerase Chimera - A DNA polymerase chimera comprising an amino-terminal (N-terminal) region encoding a φ29 type DNA polymerase and a carboxyl-terminal (C-terminal) region comprising at least one HhH domain which are bound by a connecting amino acid sequence is disclosed along with and the use thereof for replicating, amplifying or sequencing a template DNA. Also disclosed is a method for replicating, amplifying or sequencing a deoxyribonucleic acid with a DNA polymerase chimera and kits for carrying out the methods. | 09-12-2013 |
20130236048 | IMAGE PROCESSOR FOR FEATURE DETECTION - Disclose embodiments include an image processor for feature detection comprising a single non-planar chip containing a plurality of integrated sensing and processing resources across two or more layers adapted to capture image frames and extract image features. In a particular embodiment, the non-planar chip is a three dimensional CMOS integrated circuit (3D CMOS IC) with vertical distribution of sensing and processing resources across two or more vertical integrated circuit layers. The 3D CMOS IC implements two or more feature detectors in a single chip by reusing a plurality of circuits employed for gradient and keypoint detection. Feature detectors include a scale invariant feature transform detector (SIFT), a Harris-based feature detector, and a Hessian-based feature detector. | 09-12-2013 |
20130209920 | POWDERED GRIT MADE OF A FUSED CERMET - Powdered grit comprising a fused cermet of zirconium oxide (ZrO | 08-15-2013 |
20130193404 | PHOTOCONVERSION DEVICE WITH ENHANCED PHOTON ABSORPTION - An infrared photoconversion device comprising a collector with at least an active layer made of a single sheet of doped single-layer, bilayer, or multilayer graphene patterned as nanodisks or nanoribbons. The single sheet of doped graphene presents high absorbance and thus, the efficiency of devices such as photovoltaic cells, photodetectors, and light emission devices can be improved by using graphene as the central absorbing or emitting element. These devices become tunable because their peak absorption or emission wavelength is changed via electrostatic doping of the graphene. | 08-01-2013 |
20130143825 | COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF TOXIC TRANSCRIPTS - Compounds to be used in the treatment of diseases based on the expression of toxic transcripts. The present invention relates to peptide molecules, specifically hexapeptides, designed for the prevention and/or treatment of diseases the etiology whereof is based on the presence of toxic transcripts that comprise CUG, CCUG, CGG, CAG and AAG repeats, preferably: DM1 SCA8, DM2, FXTAS, HD and FA. | 06-06-2013 |
20130084339 | COMPOSITION COMPRISING ALUMINUM SILICATES AND SILVER NANOPARTICLES AS BACTERICIDES - The present invention relates to a composition comprising a nanocomposite or nanostructured powder which comprises an aluminium silicate and, distributed on the surface thereof, silver nanoparticles with sizes of less than 50 nm, to its use as a bactericide and to a process for obtaining said composition. | 04-04-2013 |
20130072400 | METHOD FOR THE DIAGNOSIS/PROGNOSIS OF COLORECTAL CANCER - The present invention relates to a method for obtaining useful data for the diagnosis, prognosis or monitoring of colorectal cancer (CRC) progression, to a method for the diagnosis of CRC, to a method for the prognosis of CRC and to a kit for carrying out said methods. | 03-21-2013 |
20130040292 | NANOPARTICLE BIOSENSOR, METHOD OF PREPARING SAME AND USES THEREOF - The invention relates to the field of biosensors and, more specifically, to nanoparticle biosensors comprising: a magnetic core, a silica layer, one or more outer metal layers which can be of different types and deposited in an alternating manner and immobilized on the outer surface, and a layer of synthetic or natural organic or inorganic biosensor molecules that can bind to biomolecules. The invention also relates to a method of obtaining the nanoparticle biosensors as well as to the different uses thereof. | 02-14-2013 |
20130012522 | NEW DERIVATIVES OF PROPARGYLAMINE HAVING NEUROPROTECTIVE CAPACITY FOR THE TREATMENT OF ALZHEIMER'S AND PARKINSON'S DISEASES - The present invention relates to a compound of formula (I) wherein: R | 01-10-2013 |
20120301529 | POWDER OF VITREOUS COMPOSITION HAVING BIOCIDAL ACTIVITY - The present invention refers to the use of a powder of vitreous composition, characterised in that it has a minimum CaO content of 10% by weight, as biocide | 11-29-2012 |
20120230897 | METHOD FOR RECOVERING CO2 BY MEANS OF CaO AND THE EXOTHERMIC REDUCTION OF A SOLID - This invention involves a cyclic method for capturing CO | 09-13-2012 |
20120191685 | METHOD FOR IDENTIFYING PEPTIDES AND PROTEINS FROM MASS SPECTROMETRY DATA - The present invention relates to a method of identifying peptides and proteins from mass spectrometry data using multiple search engines, wherein: a) the scores calculated on each engine are modeled; b) the presence of matching parameters is included, c) the distribution of meta-scores using distribution functions is modeled, d) scores of peptide and precursor protein are built. Among the main advantages of the invention it is worth mentioning its flexibility to be applied to an arbitrary number of engines, the use of matching parameters that add additional information not available with a single engine, the increase in the number of peptides-proteins identified or its versatility to incorporate other additional sources of information, depending on the type of experiment being examined. | 07-26-2012 |
20120190056 | Encoded Microparticles - The present invention relates to an encoded microparticle for labeling an isolated cell or an isolated embryo characterized in that it is made of a biocompatible material and its external shape comprises a code by which it can be identified. The use of an encoded microparticle for labeling and/or tracking isolated biological material. A method of tracking an encoded microparticle in or attached to an isolated cell or embryo using an optical microscope, preferably an inverted optical microscope with an objective substantially between 20×-100×. | 07-26-2012 |
20120190014 | PHAGE PHI 29 DNA POLYMERASE CHIMERA - A DNA polymerase chimera comprising an amino-terminal (N-terminal) region encoding a φ29 type DNA polymerase and a carboxyl-terminal (C-terminal) region comprising at least one HhH domain which are bound by means of a connecting amino acid sequence is disclosed along with and the use thereof for replicating, amplifying or sequencing a template DNA. Also disclosed is a method for replicating, amplifying or sequencing a deoxyribonucleic acid with said DNA polymerase chimera and kits for carrying out said methods. | 07-26-2012 |
20120189690 | Liposomes covered with the Extracellular Domain of the APO2L/Trail Protein - The invention relates to the field of biotechnology and medicine. The invention specifically relates to a compound comprising a liposome covered or decorated at least with the extracellular domain of the APO2L/TRAIL protein, and to the use thereof far developing a medicament preferably for the treatment of a cancer or inflammatory or autoimmune diseases, such as rheumatoid arthritis. | 07-26-2012 |
20120178092 | Method for the Replication, Amplification or Sequencing of a DNA Template - Methods for replicating, amplifying or sequencing a deoxyribonucleic acid with a φ29 type DNA polymerase are disclosed, along with kits for carrying out the methods. | 07-12-2012 |
20120172960 | SU-8 MICRONEEDLES FOR MONITORING AND STIMULATING NEURONS - An SU-8 microneedle for monitoring and stimulating neurons, has a thickness less than 100 micrometers and a length of 50 micrometers to 10 centimeters. A manufacturing method allows removing the microneedle from the substrate without using mechanical devices due to the initial coating of a rigid substrate with an aluminium layer as a sacrificial layer and the final chemical etching of the aluminium layer for chemically removing the microneedle obtained in known intermediate photolithographic manufacturing steps. | 07-05-2012 |
20120167253 | POLYNUCLEOTIDE COMPRISING SEQUENCES OF WHEAT GLIADINS AND USE THEREOF FOR SILENCING BY RNAI - The present invention relates to the specific silencing of the α (alpha), β (beta), γ (gamma) and ω (omega)-gliadins of hard wheat for flour by RNA interference (RNAi) through employment of a polynucleotide which is transcribed into an hpRNA (hairpin RNA). Furthermore the present invention additionally relates to a vector, cell, plant or seed comprising the polynucleotide, the expression whereof is specifically directed in particular tissues of wheat seeds through gene expression-regulating sequences such as, for example, the promoter of a gene of γ-gliadins or the promoter of the gene encoding for a D-hordein. | 06-28-2012 |
20120141602 | SYSTEMS CONTAINING MAGNETIC NANOPARTICLES AND POLYMERS, SUCH AS NANOCOMPOSITES AND FERROFLUIDS, AND APPLICATIONS THEREOF - The present invention relates to a system comprising magnetic nanoparticles of a metal oxide and a polymer, which in turn contains monomers with different functional groups. This system can be solid (nanocomposite) or liquid (ferrofluid). The present invention also relates to a process for obtaining the system, as well as its use, mainly in biotechnological, veterinary and medical applications, such as, for example, for the diagnosis and treatment of human diseases. | 06-07-2012 |
20120136237 | COMPACT, HYBRID AND INTEGRATED GAMMA/RF SYSTEM USED TO FORM SIMULTANEOUS PET OR SPECT AND MR IMAGES - The GAMMA/RF compact, hybrid and integrated system for PET-SPECT/MR simultaneous imaging of the invention comprises a GAMMA/RF device that integrates an RF coil, of the type used in conventional MR systems, with GAMMA radiation detector modules of the type used in PET or SPECT systems, so that combined PET or SPECT and MR images are obtained. | 05-31-2012 |
20120135041 | IMMUNOSUPPRESSOR BASED ON THE BLOCKAGE OF TCR-NCK INTERACTION - The present invention relates to a compound of structural formula (I) and its derivatives for use as medicinal drugs. They are preferably immunosuppressive agents, with mechanism of action based on the blockage of TCR-Nck interaction. | 05-31-2012 |
20120131931 | Capacitive Separator Device - A device is disclosed which is designed to separate water, hydrocarbons and gases, based on the electric characteristics of the materials; the device utilises the different capacitance of water and hydrocarbons. | 05-31-2012 |
20120129877 | USE OF QUINAZOLINE DERIVATIVES FOR NEURODEGENERATIVE DISEASES - The present invention relates to the use of a series of quinazoline-derived compounds to produce a medicament for the treatment and/or prevention of neurological and/or neurodegenerative diseases, such as Parkinson's disease or Alzheimer's disease. The present invention also relates to a method for the treatment and/prevention of neurological and/neurodegenerative diseases comprising the administration of a therapeutically effective amount of said compounds. | 05-24-2012 |
20120122203 | METHODS AND KITS TO GENERATE miRNA- AND SMALL RNA-EXPRESSING VECTORS, AND ITS APPLICATION TO DEVELOP LENTIVIRAL EXPRESSION LIBRARIES - The invention relates to novel expression systems for microRNAs (miRNAs) based on the expression of the sense and antisense strand from convergent promoters. The invention also provides a method for the direct cloning of small RNAs present in an RNA preparation by the direct ligation of the small RNAs present within the preparation to vectors. Interestingly, if the vectors contain convergent promoter regions, the vectors isolated according to the method of the invention can be used for the direct expression of the small RNA without the need of using the DNA encoding for the small RNA precursor molecule. | 05-17-2012 |
20120104765 | DEVICE FOR GENERATING ELECTRIC POWER FROM SMALL MOVEMENTS - This invention describes a device for the generation of electric energy from small movements which comprises: a magnet with the shape of a solid of revolution which comprises at least a couple of poles (N, S) placed around an axis of revolution; a tube whose transversal section is complementary to the shape of the magnet, and which comprises a winding rolled transversally around it, with the magnet placed in the interior of the tube so that an inclination of the tube causes the magnet to roll, traveling along the interior of the tube and inducing tension on the winding. | 05-03-2012 |
20120076809 | METHOD TO INHIBIT THE BIOLOGICAL ACTIVITY OF CALCINEURIN WITH SELECTIVE PEPTIDES - The invention relates to the biotechnology sector involving the area of human health. More specifically, the invention is based on the surprising usefulness of peptides LxVPc1, c3 and c4 as efficient selective inhibitors of the calcineurin signalling pathway (CN)-NFAT and the phosphate activity of CN. Said compounds are useful immunosuppressors and serve as a base for the preparation of therapeutic compositions for the prophylactics and treatment of human diseases associated with T-lymphocyte activation, including, but not limited to, autoimmune diseases, inflammation and allergy or transplant rejections. In addition, said peptides and the associated biological and genetic material can form useful tools for the development of tests that can be used to find compounds that have a selective antagonist activity in relation to CN. | 03-29-2012 |
20120046368 | METHOD FOR PURIFYING 3,4-DIHYDROXYPHENYLGLYCOL (DHPG) FROM PLANT PRODUCTS - Process for purifying 3,4-dihydroxyphenylglycol (DHPG) from any part of the plant, from the products or by-products derived from olive trees or any other vegetable product of the families Oleaceae, Orobanchaceae, Plantaginaceae, Compositae, Lamiaceae, Acanthaceae and/or Scrophulariaceae, and which comprises 1 or more steps wherein the initial product is introduced into at least one ion-exchange resin column, and in potentially subsequent steps the product eluted in the preceding column is introduced into an ion-exchange resin and/or a non-ionic adsorption resin column. Moreover, it relates to the DHPG extract obtainable by means of the process disclosed and to the applications thereof. | 02-23-2012 |
20120040005 | NANOSTRUCTURED CALCIUM-SILVER PHOSPHATE COMPOSITE POWDERS, PROCESS FOR OBTAINING THE POWDERS, AND BACTERICIDAL AND FUNGICIDAL APPLICATIONS THEREOF - Described in example embodiments are nanocomposite powders including calcium phosphate and silver nanoparticles on the surface of the calcium phosphate. Other example embodiments, describe methods of forming nanocomposite powders comprising a) preparing a nanometric calcium phosphate by a sol-gel processing route; and b) depositing silver nanoparticles on the calcium phosphate surface. Compositions including nanocomposite powders and uses of those compositions are also described. | 02-16-2012 |
20120027730 | USES OF MESENCHYMAL STEM CELLS - The invention relates to the use of mesenchymal stem cells (MSCs) for treating systemic inflammatory response syndrome (SIRS) in a subject. The invention provides compositions, uses and methods for the treatment of SIRS. | 02-02-2012 |
20120017337 | GENES REGULATING PLANT BRANCHING, PROMOTORS, GENETIC CONSTRUCTS CONTAINING SAME AND USES THEREOF - The invention relates to genes coding for TCP family transcription factors and having a biological role in the development of axillary buds and branch growth. Furthermore, the invention relates to the promoters of the transcription of said genes, to the genetic constructs containing same and to the uses thereof, including the use of agents that modulate the expression of these genes in order to modify plant architecture. | 01-19-2012 |
20120004308 | METHOD FOR OBTAINING SOLID MICRO- OR NANOPARTICLES - The invention provides a novel method for obtaining solid micro- or nanoparticles with a homogeneous structure. A method is provided for obtaining solid micro- or nanoparticles with a homogeneous structure having a particle size of less than 10 μm where the processed solid compound has the natural, crystalline, amorphous, polymorphic and other features associated with the starting compound. In accordance with the invention a method which also makes it possible to obtain solid micro- or nanoparticles with a substantially spheroidal morphology is provided. | 01-05-2012 |
20110275838 | METHOD FOR OBTAINING CINATRINS C3 AND C1 - The present invention relates to a process for obtaining cinatrins C | 11-10-2011 |
20110269948 | Method for Identifying Compounds for Cancer Therapy - The present invention relates to an in vitro method for identifying and evaluating compounds useful in the treatment of different types of cancer, especially lung, breast, colorectal and bladder cancer in an individual, for determining the stage or severity of said cancer in the individual, or for monitoring the effect of the therapy administered to an individual having said cancer; to finding, identifying, developing and evaluating the efficacy of compounds for the therapy of said cancer, for the purpose of developing new medicinal products; as well as to agents inhibiting the expression and/or activity of the choline kinase alpha protein and/or the effects of this expression. | 11-03-2011 |
20110253901 | DEVICE FOR DETECTING HIGHLY ENERGETIC PHOTONS | 10-20-2011 |
20110212223 | MUTANTS OF LACTOBACILLUS CASEI DEFECTIVE IN CARBON CATABOLISM REGULATION - The invention relates to the use of mutants of | 09-01-2011 |
20110178124 | PYRIDINIUM AND QUINOLINIUM DERIVATIVES - The invention provides compounds of formula I blocking phosphorylcholine biosynthesis by means of the selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infection and therefore being applicable in the treatment of tumors and parasitic diseases or diseases produced by viruses and fungi in animals, including human beings; as well as to a method for preparing the compounds of the invention and certain intermediates of said method. | 07-21-2011 |
20110177126 | BACTERIA AND DERIVED PRODUCTS TO REINFORCE THE BODY DEFENCES AND TO REDUCE THE RISK OF DISEASE - This invention relates to a new strain of the genus | 07-21-2011 |
20110149400 | PROCESS FOR PREPARING MULTILAYERS WITH AN ORDERED MESOPOROUS STRUCTURE, MATERIAL OBTAINED IN THIS MANNER, AND USE - The present invention relates to a process for producing multilayers formed by thin mesoporous films of oxides or hybrid organic/inorganic materials by means of a combination of sol-gel methods, self-assembly of surfactants and selective functionalization of the surfaces of the pores. Each of the constituent layers has a chemical composition, thickness, and index of refraction. | 06-23-2011 |
20110145938 | METHOD FOR GENERATING MONOCLONAL ANTIBODIES THAT RECOGNIZE PROGENITOR CELLS - Method for generating monoclonal antibodies that recognize progenitor cells. Said method comprises immunization of an Armenian hamster with neurospheres obtained from olfactory bulb cells from a 13.5-day mouse embryo and subsequent selection of the antibodies by means of neurosphere flow cytometry in the presence of propidium iodide. The antibodies thus obtained may be of use in the enrichment of cell cultures in progenitor cells, primarily neural progenitor cells. | 06-16-2011 |
20110142879 | INFECTIOUS CLONES - Methods of preparing a DNA comprising sequences derived from the genomic RNA (gRNA) of a coronavirus are provided, comprising cloning under the expression of a promoter a coronavirus interfering defective genome into a bacterial artificial chromosome (BAC) and reinserting into said genome the deleted sequences within the defective genome, wherein said sequences have a homology of at least 60% to the natural sequence of the virus, wherein said sequences code for an RNA-dependent RNA polymerase and at least one structural or non-structural protein, and wherein a fragment of said DNA is capable of being transcribed into RNA and assembeld to a virion. Also provided are infective clones, recombinant viral vectors, and vaccines. | 06-16-2011 |
20110136898 | TREATMENT OF RETINAL DEGENERATION - The use of a compound of general formula (I): or a pharmaceutically acceptable salt thereof, in the manufacture of a medicament for the treatment or prevention of a disease or condition characterised by apoptosis or degeneration of mammalian cells, wherein: R1 is a alkoxy, alkyl, ether or ester group; R2 is H or has the formula wherein Y is linear or branched, saturated or unsaturated, aliphatic group with from 2 to 23 carbon atoms, or a cyclic group, and which can contain substituents selected from the group consisting of hydroxyl, alkoxy, amino, carboxyl, cyano, nitro, alkylsuphonyl or halogen atoms, X is O or S; and R3 is any substituent. | 06-09-2011 |
20110097354 | SYSTEM FOR THE EXPRESSION OF PEPTIDES ON THE BACTERIAL SURFACE - Expression system of peptides on the bacterial surface characterised in that membrane-binding region the conserved sequence of the MSP1a protein of | 04-28-2011 |
20110075903 | METHOD AND SYSTEM FOR THE ANALYSIS OF PECULIARITIES IN FINGERPRINTS - The proposed method comprises determining for each point of the signal an environment comprising the first neighbours and calculating for each point of the signal a reconstructibility measurement, or singularity measurement, weighting the contributions of said local environment of the point. The value of the signal at each point is inferred from the values of the signal at the points of the local environment using a reconstruction formula. The singularity measurement includes the difference between the value of the signal at the point and the value estimated by its local environment. A logarithmic transformation is carried out on said singularity measurement with a view to obtaining an independent measurement of the amplitude of the sampled digital signal that varies in a controlled manner under changes in resolution. | 03-31-2011 |
20110070234 | NP1 ACTIVITY REGULATING ELEMENTS USEFUL FOR THE PRODUCTION OF DRUGS FOR THE TREATMENT OR PREVENTION OF HUMAN NEURODEGENERATIVE DISEASES, RESULTING DRUGS AND USE THEREOF - The invention relates to a series of compounds useful for the production of drugs or pharmaceutical compositions for the treatment or prevention of human neurological diseases, preferably neurodegenerative diseases, which inhibit the activity of the human NP1 protein which acts as an inducer of neurodegeneration and neural apoptosis. Said compounds include iRNA inhibitors of the gene expression of the NP1 gene and specific antibodies of the human NP1 protein, as well as peptides derived from same, which can be used in passive and active immunisation methods respectively against said diseases. | 03-24-2011 |
20110065582 | ENVIRONMENTALLY FRIENDLY SLOW-RELEASE PESTICIDE FORMULATIONS - The present invention relates to a slow-release pesticide system in agrarian applications that includes but is not limited solely to insecticide, fungicide and herbicide formulations. The system includes a pesticide incorporated into vesicles that is formed by neutral lipids (thereby enhancing the water solubility of the pesticide). The vesicles that incorporate the pesticide are, in turn, adsorbed, on a clay mineral. The formulations are appropriate for pesticide molecules of any type (hydrophobic, acid and basic). Said pesticide formulation allows slow release of the active ingredient, thereby reducing the risk of pollution of groundwater and surface water. | 03-17-2011 |
20110064775 | METALLO-ORGANIC SYSTEM FOR THE ENCAPSULATION AND RELEASE OF COMPOUNDS OF INTEREST, METHOD FOR OBTAINING SAME AND USES THEREOF - The present invention discloses a metallo-organic system that includes: a metal ion salt or complex; at least one organic ligand; and a substance of interest to be encapsulated, belonging to the group comprising a biological entity, a drug, a vaccine, a diagnostic contrast agent, a marker, an organic compound, an inorganic compound, a metallo-organic compound or a nanomaterial or nanodevices. Also disclose is the process for obtaining same and the uses thereof for the release and/or protection and/or storage of said substances in the pharmaceutical, chemical, environmental, medical and industrial sectors. | 03-17-2011 |
20110054025 | USE OF A PENTACYCLIC TRITERPENE IN A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MULTIPLE SCLEROSIS - Oleanolic acid (3β-hiydroxyolean-12-en-28-oic acid) is a pentacyclic triterpene occurring in a large number of medicinal plants. The present invention is directed to the pharmacological application of the oleanolic acid, alone or in combination with other substances, in the treatment or prophylaxis of neurodegenerative diseases such as multiple sclerosis. The inventors have found that oleanolic acid, intraperitoneally administered once daily, reduces significantly the immuno-inflammatory and neurological symptoms associated with the experimental autoimmune encephalomyelitis, an experimental model of multiple sclerosis, delaying the onset and reducing the progression of the disease. | 03-03-2011 |
20110035157 | BIOMASS CONCENTRATION MEASUREMENT DEVICE AND METHOD AND USE OF AN ELECTRONIC CHIP ELEMENT FOR MEASURING SAID BIOMASS CONCENTRATION - The invention relates to devices and methods for measuring a concentration of a biomass suspended in a medium. Embodiments of the device include a substrate capable of being immersed in the medium, at least two electrodes integrated in the substrate, and a processing and control circuit electromagnetically coupled to the at least two electrodes. The processing and control circuit is configured to apply an electrical potential to the at least two electrodes, the applied electrical potential generating a stationary electric charge that leads to the appearance of an electrical double layer on a surface of one of the at least two electrodes and that causes a biomass electrostatic adhesion on the surface, measure a change in capacitance of the electrical double layer in response to the biomass electrostatic adhesion, and determine the concentration of the biomass using a calibration curve that correlates the change in capacitance with the concentration. | 02-10-2011 |
20110010794 | METHOD FOR IMPROVING PLANT TOLERANCE TO ENVIRONMENTAL STRESS - Provided are DNA sequences encoding a novel type of AP2 domain-containing transcription factor as well as methods for obtaining similar sequences. Also described are methods for obtaining plants with improved growth and enhanced stress tolerance, particularly tolerance to osmotic and dehydration stress, such methods comprising expression of such DNA sequences in a plant or parts thereof. Further described are diagnostic compositions comprising the aforementioned DNA sequences and the use of such sequences in plant breeding and/or agriculture. | 01-13-2011 |
20100331355 | Substituted Quinolines for the Treatment of Cancer - Compounds of formula G | 12-30-2010 |
20100310520 | MICROORGANISMS FOR IMPROVING THE HEALTH OF INDIVIDUALS WITH DISORDERS RELATED TO GLUTEN INGESTION - The invention relates to microorganisms for the treatment of food allergies, specifically coeliac disease, as well as to methods for the selection thereof. The action mechanisms of said microorganisms include: (i) the regulation of the innate and adaptive immunological responses; (ii) the reduction of the concentration of toxic gluten peptide epitopes in the intestinal lumen; (iii) the strengthening of the barrier defence function against harmful antigens and bacteria; and (iv) the provision of enzymatic activities that promote digestion. | 12-09-2010 |
20100305157 | DERIVATIVES OF DICARBOXYLIC AMINO ACIDS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES - Products of a general formula (I) and their use in the manufacture of medicines useful for the treatment of neurodegenerative diseases such as Alzheimer's disease or, in general, any disease or pathology produced by alterations of biological functions that can be treated or therapeutically modified by these products. | 12-02-2010 |
20100271591 | ANALYTICAL DESIGN OF INTRAOCULAR LENSES - The invention relates to a method for designing intraocular lenses, comprising: the definition of a pseudoaphakic eye model; the definition of a merit function in multiple dimensions, which analytically connects the quality of the image on the retina to the optical and geometric parameters of the pseudoaphakic eye model; and the algorithm optimisation of the previous merit function using analytical and numerical methods in order to obtain one or more minimum globals which provide the optimal parameters of the intraocular lens for the pseudoaphakic eye model. | 10-28-2010 |
20100242675 | MODIFIED INDUCTION FURNACE AND PROCESS FOR REMOVING ZINC-CONTAINING METALLURGICAL WASTE, WITH RECOVERY OF THE METALS THEREFROM - The present invention is based on a novel electric induction furnace design that enables the removal of zinc-containing filter dust (FD) originating from the production of steel (alloy or non-alloy) and the production of cast iron with galvanised steel scrap, using a novel process based on the carbothermal reduction of the metal oxides present in the FD, performed at the temperature at which the materials are melted inside the electric induction furnace. The electric induction furnace of the invention incorporates an electric arc or plasma beam generator to melt all the inorganic non-metallic material. The incorporation of this generator also enables the use of large volumes of molten slag. | 09-30-2010 |
20100242133 | MANIPULATION OF THE FUNCTION OF AtDBP1 IN ORDER TO GENERATE POTYVIRUS RESISTANCE - The invention relates to the use of a mutation for the generation of virus-resistant mutant plants and, specifically, to the use of mutation 8.1 of the AtDBP1 gene of | 09-23-2010 |
20100216173 | CITRULLINATED FIBRIN-FILAGGRIN CHIMERIC POLYPEPTIDE CAPABLE OF DETECTING THE ANTIBODIES GENERATED IN RHEUMATOID ARTHRITIS - The present invention concerns a chimeric polypeptide, capable of detecting the antibodies generated in rheumatoid arthritis, comprising at least two citrulinated peptide subunits: (i) one derived from the α or β chain of the fibrin and (ii) a second derived from the filaggrin. In addition, the invention comprises an antigenic composition, a method and a kit for the diagnosis of rheumatoid arthritis, from the detection of the autoantibodies generated during the course of said disease. | 08-26-2010 |
20100206351 | PHOTONIC USE OF INTERMEDIATE BAND MATERIALS ON A CHALCOGENIDE-TYPE SEMICONDUCTOR - The invention relates to the use, in the manufacturing of materials or devices for photonic applications, of chalcogenide-type compounds having an octahedrally coordinated indium element and wherein a transition element is introduced in octahedral position generating a partially occupied intermediate band separate from those of valence and conduction of the initial semiconductor, according to quantum mechanics calculations. This enables, by absorption of two photons having energy lower than the prohibited bandwidth of the initial semiconductor, a result equivalent to that achieved, without said intermediate band, by the absorption of a higher-energy photon. The use of such a material can thereby improve yield and performance of various photovoltaic, photocatalytic, photoelectrochemical, optoelectronic or photonic conversion devices. Indium sulfide substituted in part with vanadium or titanium is one of the specific materials having these properties that is synthesised according to the invention. | 08-19-2010 |
20100203115 | ORGANIC-INORGANIC HYBRID MATERIAL FOR THE STORAGE AND RELEASE OF ACTIVE PRINCIPLES - This invention relates to a hybrid material composed of organic-inorganic particles, characterised in that said particles have a diameter of between 10 and 800 nm, and it is structured in two portions:
| 08-12-2010 |
20100193378 | IMPEDIMETRIC SENSOR AND APPLICATIONS THEREOF - The invention relates to a highly sensitive impedimetric sensor in which the highly conductive electrodes are separated by a barrier of insulating material. Said sensor is used to determine directly the presence of analytes in a biological sample of human, veterinary or environmental origin. | 08-05-2010 |
20100184850 | PHENOLIC EXTRACTS OF ALMOND PEEL CONTAINING PROCYANIDINS, PROPELARGONIDINS, AND PRODELPHINIDINS, AND METHOD FOR PREPARATION THEREOF - The present disclosure concerns phenolic extracts containing procyanidins, propelargonidins and prodelfinidins obtained from peel of the almond [ | 07-22-2010 |
20100179224 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 07-15-2010 |
20100148111 | Ce-N-O SYSTEM DERIVED FROM DOPING OF CERIUM OXIDE WITH NITROGEN HAVING GENERAL FORMULA CeO2-x-yNx - Ce-N-O system derived from doping of cerium oxide with nitrogen with general formula CeO | 06-17-2010 |
20100143330 | METHODS OF TREATING DISORDERS ASSOCIATED WITH FAT STORAGE - The invention relates, in general, to markers of obesity and lipodystrophy. In particular, the expression level of the SLUG gene or its expression products can be used as such a marker. Furthermore, the invention additionally relates to the use of SLUG as a therapeutic and diagnostic target for these pathologies. The invention further relates to a method of treating a disorder associated with increased or decreased fat storage in a mammal comprising modulating the activity or level of the SLUG protein or the SLUG gene in the mammal. | 06-10-2010 |
20100129258 | FUNCTIONALIZATION OF A SUBSTRATE SYSTEM AND METHOD - Disclosed herein are embodiment relating to a methods of obtaining a functionalized porous or fibrous solid substrate with the chemical and/or physical properties of a nano-structured molecular or polymer chemical compound that contains it. In accordance with some example embodiments, the properties of the starting substrate may be modified to obtain a new functionalized substrate. The new substrate may have various applications, such as, for example, an optical- and/or fluorescent-type chemical sensor, as a chemical sequestrator, or as a modifier of the properties of a surface, making it, for example, superhydrophobic. | 05-27-2010 |
20100120675 | INHIBITOR OF THE URACIL-DNA GLYCOSYLASE ENZYME AND USES THEREOF - The present invention relates to a protein which has the capacity to bind to and inhibit the viral uracil DNA glycosylase (UDG) enzyme and its use as a therapeutic agent; in particular, as an antiviral agent. | 05-13-2010 |
20100120124 | SYSTEMS, METHODS AND MICRORGANISMS FOR ANTIBODY PRODUCTION WITH TYPE III SECRETION SYSTEM - Exemplary embodiments disclosed herein include a microorganism that produces, secretes and injects recombinant antibodies into eukaryote cells said the described microorganisms can be used to prepare pharmaceutical compositions for the treatment of human or veterinary diseases. | 05-13-2010 |
20100115668 | Ocp3 gene of arabidopsis thaliana and the ocp3 recessive mutation thereof, and the use of same as a resistance regulator in plants with disease caused by necrotrophic fungal pathogens - The invention relates to the technical field of plant biotechnology and, more specifically, to the OCP3 gene of | 05-06-2010 |
20100099899 | METHOD FOR EXTRACTING INTERNAL LIPIDS FROM WOOL USING SUPERCRITICAL FLUIDS - A method for extracting internal lipids from wool that is substantially free of lanolin, comprising the use of a fluid under supercritical conditions and an agent that can change the polarity of said fluid, selected from methanol and/or ethanol, is disclosed. According to the operating conditions described, the temperature is between 40° C. and 120° C., and the pressure is between 120 bars and 330 bars. The polarity-changing agent represents between 3% and 15% expressed as volume/volume. The inventive method can be used to obtain internal lipids from wool, one of the most significant components of which are ceramides, which can be used in compositions intended to protect human skin against environmental damage. | 04-22-2010 |
20100095904 | EQUIPMENT FOR ASEPTIC HANDLING OF LABORATORY ANIMALS - Disclosed herein are systems and methods to move animals. | 04-22-2010 |
20100086648 | CARAMELS WITH HIGH CONTENT IN PREBIOTIC OLIGOSACCHARIDES, PROCEDURE OF PREPARATION AND USE - The present invention relates to the transformation of food-grade sugars containing D-fructose, in caramels enriched in oligosaccharides with prebiotic activity by using solid acid catalysts, such as zeolites, clays or ion-exchange resins in its acid form, under heterogeneous conditions, or by using soluble acid polymer catalysts of high molecular weight, under homogeneous conditions, with the possibility of recycling the catalyst, being compatible with discontinuous or continuous production processes. The resulting caramel exhibits prebiotic properties, favoring the development of a beneficial intestinal flora and a repairing effect in the damaged colon. | 04-08-2010 |
20100053831 | WIDEBAND OVERVOLTAGE PROTECTION CIRCUIT - The present patent application describes an approach to the protection of voltage sensitive instruments using a protection circuit that may be easily integrated in a three-terminal device, and which overcomes the drawbacks of previous approaches. The protection circuit of the invention performs very fast against overvoltages (in a few nanoseconds), automatically switching to a low impedance conduction state as soon as the overvoltage situation ends. It also minimizes insertion losses, shows a very low level of thermal noise and allows for obtaining broad bandwidths due to its low serial impedance in the conduction state. Furthermore, it does not require any power source or control signal. | 03-04-2010 |
20100048712 | Acyclic Sulfamide Derivatives - The present invention is related to acyclic sulphamide derivatives of formula (I), wherein R | 02-25-2010 |
20100034736 | IDENTIFICATION OF CANCER STEM CELLS USING GENETIC MARKERS - The invention relates to the identification of markers for cancer stem cells. These markers can be used in a number of different ways, including diagnosis and therapy. In particular, the invention relates to a method of detecting, identifying and/or quantifying cancer stem cells, the method comprising the step of assessing the level of expression; the activity; or the sequence of the SLUG, OVOL1 and/or OVOL2 gene, promoter and/or expression product in a cell. | 02-11-2010 |
20100009417 | Chemoenzymatic process for the preparation of iminocyclitols - The present invention discloses a chemoenzymatic process for the preparation of an iminocyclitol corresponding to formula (I), (II), (III) or (IV), wherein: R | 01-14-2010 |
20100009391 | METHOD FOR EXTRACTING GLUTEN FROM PROCESSED AND UNPROCESSED FOODS BY MEANS OF HEAT BASED ON THE USE OF IONIC AND NON-IONIC DETERGENTS - The present invention relates the analysis of foods for celiac patients. In particular, the invention includes: a method for extracting gluten from foods, which is compatible with an enzyme-linked immunosorbent assay (ELISA) and with the Western Blot technique; compositions suitable for implementing this method; kits that comprise these compositions; a method for the quantification of the gluten present in a food. | 01-14-2010 |
20100009056 | LIQUID AND STABLE OLEIN FRACTIONS - The present invention relates to a stable and liquid olein fraction wherein less than 8.6% of the TAG species of said olein fraction have the general formula SMS and at least 26% of TAG species of said olein fraction have the general formula SMM, wherein S represents a saturated fatty acid and M represents a monoenoic fatty acid, which olein fraction is obtainable by fractionation of a high oleic high saturated sunflower oil; and collecting the liquid fraction. The invention further relates to a method for preparation of a stable and liquid olein fraction by low temperature fractionation of a high oleic, high saturated sunflower oil. | 01-14-2010 |
20090304575 | IN VITRO METHOD FOR IDENTIFYING COMPOUNDS FOR CANCER THERAPY - The present invention relates to an in vitro method for identifying and evaluating compounds useful in the treatment of different types of cancer, especially lung, breast, colorectal and bladder cancer in an individual, for determining the stage or severity of said cancer in the individual, or for monitoring the effect of the therapy administered to an individual having said cancer; to finding, identifying, developing and evaluating the efficacy of compounds for the therapy of said cancer, for the purpose of developing new medicinal products; as well as to agents inhibiting the expression and/or activity of the choline kinase alpha protein and/or the effects of this expression. | 12-10-2009 |
20090275085 | Enzyme for Obtaining Prebiotic Oligosaccharides - An industrially viable process of obtaining prebiotic oligosaccharides using a new | 11-05-2009 |
20090263043 | BLIND DECONVOLUTION AND SUPER-RESOLUTION METHOD FOR SEQUENCES AND SETS OF IMAGES AND APPLICATIONS THEREOF - The present invention relates to the image achieved by any conventional method of capture and their subsequent computer processing. The process of the invention presented is based on the simultaneous processing of the input images and their restoration (deconvolution) pixel by pixel by means of a new mathematical method. Furthermore, and in the case of having more than one image of the scene in question, the system is capable of providing superresolution of the input images. It has direct application in digital photographic cameras, digital video cameras, mobile phones, video and photography edition programmes, image analysis programmes for microscopy and astronomy, analysis of medical images, forensic image, image-based security systems, aerial image and in the restoration of works of art, among others. | 10-22-2009 |
20090246813 | SELECTIVE ACCELERATION OF FRAGMENTATION THROUGH JOINT APPLICATION OF ENZYMES AND ULTRASOUND - The present invention refers to an acceleration process for macromolecular fragmentation in liquid medium, in gel or in a solid support, by means of joint application of enzymes and ultrasounds, as well as isotopes. The macromolecules, in any of these liquids, are mixed with enzymes and inserted in a recipient ( | 10-01-2009 |
20090230105 | Continuous Furnace with Coupled Laser for the Surface Treatment of Materials - The present invention relates to a continuous kiln coupled to a laser by a conventional optical means that allows for surface treatment of a part, such that it is possible to achieve temperatures of up to 3000° C. on the surface of the part while the remainder of the part is at a substantially lower temperature. The part in the kiln is heated to a temperature on the order of 500° C. and a laser beam bundle is applied to the part via an opening in the kiln. The laser beam scans a line perpendicular to the direction of movement of the part such that the entire surface is scanned by means of the mechanical advance of the part. The scanning may extend beyond the lateral ends of the part. The kiln may comprise different zones with independent temperature controls for successfully achieving desired values, both for heating and cooling. | 09-17-2009 |
20090222932 | ALZHEIMER'S DISEASE ANIMAL MODEL, METHOD FOR OBTAINING SAME AND USES THEREOF - The invention relates to a transgenic non-human animal which can be used as a non-human animal model for studying Alzheimer's disease (AD) and which is characterized in that: it contains a heterologous polynucleotide (transgene) which is inserted in the genome thereof and which comprises the nucleotide sequence of the complete human APP gene together with the regulatory sequences thereof; and it has an endogenous expression pattern similar to that of the hAPP gene in humans. The inventive model can be used to study AD and in the screening of potentially-useful compounds for the prevention and/or treatment of AD. | 09-03-2009 |
20090220661 | MICROPOROUS CRYSTALLINE MATERIAL, ZEOLITE ITQ-37, PREPARATION METHOD AND USE - The present invention relates to a microporous crystalline material characterized in that it has the following chemical composition in the calcined from: | 09-03-2009 |
20090202503 | SEQUENCE OF NUCLEOTIDES AND PEPTIDES GSE 24.2 OF DYSKERIN, WHICH CAN INDUCE TELOMERASE ACTIVITY, METHOD FOR OBTAINING SAME, THERAPEUTIC COMPOSITIONS AND APPLICATIONS THEREOF - This invention relates to a compound that induces or activates telomerase activity based on the nucleotide sequence of the GSE 24.2 fragment of dyskerin or the protein or peptide sequence encoded by said nucleotide sequence. Another part of the invention relates to vectors that comprise said sequence and cells transformed thereby, and pharmaceutical compositions that contain all these elements. These compositions may be used in the treatment of diseases from the following group: ageing or acceleration of ageing, neurodegenerative diseases and dyskeratosis congenita. | 08-13-2009 |
20090169462 | PRECALCINATION METHOD WITH PRODUCTION OF PURE OR EASILY PURIFIED CO2 ORIGINATING FROM THE DECOMPOSITION OF CARBONATES - The method proposed consists in superheating a stream of calcined material (normally CaO) to a temperature above the calcination temperature and circulating this superheated stream of calcined material to the calciner, where the solids release heat. This calciner is also supplied with the stream of material to be calcined (normally preheated CaCO | 07-02-2009 |
20090155849 | GENERATION OF SPECIFIC ADHESION IN GRAM-NEGATIVE BACTERIA BY MEANS OF ANCHORING IMMUNOGLOBULIN SINGLE DOMAINS ON THEIR SURFACE WITH AUTOTRANSPORTERS - The present invention refers to an expression vector for gram-negative bacteria allowing for the production of hybrid proteins between single domain recombinant antibodies and a transporter domain of an autotransporter, as well as to its anchoring and expression on the external surface of a bacterial membrane, and to a method of specific bacterial adhesion to a surface containing a specific antigen. | 06-18-2009 |
20090148907 | NOVEL FRUCTOFURANOSIDASE ACTIVITY FOR OBTAINING THE PREBIOTIC OLIGOSACCHARIDE 6-KESTOSE - The invention relates to a novel fructofuranosidase activity for obtaining the prebiotic oligosaccharide 6-kestose. One object of the invention is to characterize a novel transfructosylase activity which is associated with the extracellular invertase of | 06-11-2009 |
20090142808 | NOVEL ENZYME WITH FRUCTOFURANOSIDASE ACTIVITY, WHICH IS USED TO OBTAIN PREBIOTIC OLIGOSACCHARIDES - The invention relates to a method of obtaining industrially-viable prebiotic oligosaccharides, using a novel extracellular enzyme (fructofuranosidase) of | 06-04-2009 |
20090142649 | BIOLOGICAL ELECTRODE WITH THE HYDROGENASE ENZYME, METHOD OF OBTAINING SAME AND APPLICATIONS THEREOF - The present invention relates to biological electrodes modified with hydrogenase enzymes (anodes), by means of which it is possible to produce electrical energy from hydrogen in a typical fuel cell configuration. Likewise, using these hydrogenase-modified electrodes (cathodes), it is possible to produce hydrogen from water in a typical electrochemical cell configuration. The methods of making the biological electrodes of the present invention and applications thereof are also described. | 06-04-2009 |
20090138993 | Sunflower seeds with high delta-tocopherol content - The present invention relates to sunflower seeds which have been genetically modified through two artificial induction cycles of mutations followed in each case by processes for the identification of mutant individuals which have the desired character. The disclosed seeds are characterised in that they contain between 26% and 80% of the tocopherols as delta-tocopherol. This high delta-tocopherol production is determined by the genotype of the seeds which have been modified to this effect, and is always obtained independently of the culture conditions, thereby obtaining an inheritable character. Today, sunflower seeds producing such high levels of delta-tocopherol do not exist. Genetically modified sunflower plants which produce through self-fertilisation seeds with high delta-tocopherol levels and the oil with high natural delta-tocopherol concentration, extracted from the seeds, are also objectives of the present invention. | 05-28-2009 |
20090119192 | SYSTEM AND METHOD FOR REGISTERING AND CERTIFYING ACTIVITY AND/OR COMMUNICATION BETWEEN TERMINALS - The invention relates to a system and method for registering and certifying activity and/or communication between terminals, of the type in which a registry and certification service provider registers the telematic content exchanged between a user and a service provider during a transaction using a registry and certification server and issues an electronic certification upon completion of the service. According to the invention, the registry and certification server is connected to an official time server in order to obtain reliable time stamps and to a client capture module which is installed in the user terminal in order to register periodic captures of the interface of the user terminal and data relating to the connections established thereby and to include same in the electronic certification document together with the reliable time stamps. The electronic certification document is authenticated using an electronic signature provided by the registry and certification service provider. | 05-07-2009 |
20090076140 | PHARMACEUTICAL COMPOSITIONS CONTAINING SULPHONIC ACID DERIVATIVES - A naphthalenesulfonic acid or quinolinesulfonic acid of formula (I), wherein A is N or a CR | 03-19-2009 |
20080259356 | SYSTEM AND METHOD FOR DETECTING THE DISPLACEMENT OF A PLURALITY OF MICRO- AND NANOMECHANICAL ELEMENTS, SUCH AS MICRO-CANTILEVERS - The invention relates to a system and method for detecting the displacement, such as the deflection, of a plurality of elements ( | 10-23-2008 |
20080206356 | Pharmaceutical Compositions for the Treatment of Neurodegenerative Disorders - Pharmaceutical compositions comprising an effective amount of a tungsten (VI) compound, preferably of a tungstate salt, and more preferably of sodium tungstate (Na | 08-28-2008 |